2A85

ICD-11 MMS 2026-01

Other specified mature B-cell neoplasms or lymphoma

Index terms

  • Other specified mature B-cell neoplasms or lymphoma

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Child codes

  • 2A85.0 – Nodal marginal zone lymphoma
  • 2A85.1 – Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach
  • 2A85.2 – Extranodal marginal zone B-cell lymphoma, primary site skin
  • 2A85.3 – Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin
  • 2A85.4 – Lymphoplasmacytic lymphoma
  • 2A85.5 – Mantle cell lymphoma
  • 2A85.6 – Burkitt lymphoma including Burkitt leukaemia
  • 2A85.Y – Further specified mature B-cell neoplasms or lymphoma

Sibling codes

  • 2A80 – Follicular lymphoma
  • 2A81 – Diffuse large B-cell lymphomas
  • 2A82 – Mature B-cell neoplasm with leukaemic behaviour
  • 2A83 – Plasma cell neoplasms
  • 2A84 – Heavy chain diseases or malignant immunoproliferative diseases
  • 2A86 – B-cell lymphoma, mixed features
  • 2A8Z – Mature B-cell neoplasms, unspecified

Foundation entity

Other specified mature B-cell neoplasms or lymphoma – http://id.who.int/icd/entity/418815799

Allowed postcoordination axes

Part of: 02: Neoplasms